Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes?

Kocabay, G.; Telci, Ayşe; Tutuncu, Yıldız; Tiryaki, B.; Ozel, Sevda; Cevikbas, U.; Okten, A.; Satman, İlhan

Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes?

Kocabay G., Telci A., Tutuncu Y., Tiryaki B., Ozel S., Cevikbas U., ...Daha Fazla

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.112, sa.11, ss.626-629, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 112 Sayı: 11
Basım Tarihi: 2011
Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.626-629
Anahtar Kelimeler: non-alcoholic steatohepatitis (NASH), alkaline phosphatase (ALP), liver fibrosis, type 2 diabetes mellitus, PREDICTORS
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: While isolated hepatosteatosis is a benign disease, in minority of cases non-alcoholic steatohepatitis (NASH) may even lead to cirrhosis in long-term. In order to find the stage of the disease and determine the prognosis, a liver biopsy is indicated. In this study, we studied the relationship of liver histopathological findings with serum levels of hepatic enzymes.